Della Rocca has taken on several CIO roles for J&J since 2019, when he became CIO for the company’s Janssen Pharmaceuticals ...

Johnson & Johnson announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational study of icotrokinra, or JNJ-2113, the first targeted oral peptide that selectively blocks the ...

Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced that it is ...

Stifel 2024 Healthcare Conference November 18, 2024 10:55 AM ETCompany ParticipantsMichael Bodner - Group President, ...

"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...